Ltd., widely known as Baurs, a leading conglomerate with diversified business interests in Sri Lanka and a pioneer and innovator in various industry verticals, celebrates its 80th anniversary this ...

Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) (the "Company"), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the appointment ...

President Trump on Thursday sent letters to 17 of the world’s largest drug companies, telling them to take more steps to ...

Paris, July 31, 2025. Sanofi announces that its half-year financial report for the period ending June 30, 2025 is now available and has been filed with the French market regulator Autorité des ...

Regeneron-partnered Dupixent, the crown jewel of Sanofi’s commercial portfolio, continued to impress with 21.1% sales growth ...

For now, Sanofi’s U.S. inventory is insulating the company from a potential 15% tariff on drugs shipped from the EU.

Sanofi SNY reported second-quarter 2025 adjusted earnings of 90 cents per American depositary share, which missed the Zacks ...

Drugmaker Sanofi said on Thursday it believes the impact from U.S. tariffs to be manageable as it raised its sales growth ...

Sanofi India Limited ( (IN:SANOFI) ) has provided an update. Sanofi India Limited announced the approval of its unaudited financial statements for the quarter and half-year ended June 30, 2025, ...

Net profit more than tripled to 3.94 billion euros, flattered by a gain from Sanofi's sale of a majority stake in its Opella consumer-healthcare arm. Business EPS came in at 1.59 euros, up 8.3% ...

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including Sanofi's $1.6B acquisition ...

Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...